logo
15:46 Aug 13

Ind-Swift Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
15.76
+0.91 (+6.13%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ind-Swift Ltd. Financials

Ind-Swift Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
15.76
+0.91 (+6.13%)
15:46 Aug 13
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

0/100
Expensive Valuation

Technical

33/100
Technically Bearish

Strength

0

Weakness

0

Opportunity

0

Threats

0

-70.45 %

ROE %

38.93 %

ROA %

52.33

EPS

-74.28

BVPS

55.01 %

Net Profit Margin

Mar 2018 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
270.57 397.71 410.96 502.25 515.23
Operating Expenses +
264.28 352.37 368.92 453.73 492.25
Raw Material
162.24 212.43 233.47 251.33 270.54
Increase Decrease in Cost
-8.08 -1.41 -15.43 29.85 -10.36
Other Manufacturing Expense
0 25.07 23.85 25.33 0
Employee Cost
48.27 63.15 69.15 78.32 91.81
Miscellaneous Expenses
135.63 93.43 134.88 158.56 232.22
Operating Profit
6.29 45.34 42.04 48.52 22.98
Other Income
10.16 23.55 11.85 57.99 47.62
Depreciation
34.63 32.07 28.67 27.11 23.5
Interest
7.05 57.16 59.76 62.94 39.16
Profit before tax and exceptio..
-25.23 -20.34 -34.54 16.46 7.94
Exceptional Items
-28.15 0.73 60.58 0 279.97
PBT
-53.38 -19.6 26.04 16.46 287.91
Provision for Taxation
0.75 0.42 0 2.23 4.46
Net Profit
-54.13 -20.02 26.04 14.23 283.45
NET Profit after MI
-50.43 -20.02 26.04 14.23 283.45
EPS
-9.36 -3.7 4.81 2.63 52.33
Operating Profit Margin (%)
2.32 11.4 10.23 9.66 4.46
Net Profit Margin (%)
-18.64 -5.03 6.34 2.83 55.01

Ind-Swift Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Promoter 55.60 55.60 55.60 55.60 55.60 55.60
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 44.40 44.40 44.40 44.40 44.40 44.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: